CE-IVDR Regulatory Consultant

Accu Scan Sciences  is seeking an experienced CE-IVDR Regulatory Consultant to lead and support European regulatory strategy for our oncology molecular diagnostics portfolio, including tumor-informed MRD assays and future kit-based products.

The consultant will provide strategic and hands-on regulatoryexpertiseto support CE-IVDR compliance, technical documentation development, performance evaluation strategy,Notified Body interactions, and commercialization of oncology molecular diagnostic products in Europe. The role will work cross-functionally with product development, clinical affairs, quality, manufacturing, bioinformatics, and external CDMO partners toestablisha scalable regulatory pathway for CE-IVDR market entry.

• Lead development ofAccuScan'sCE-IVDR regulatory strategy for oncology molecular diagnostic products.
• Assess regulatory classification and applicable conformity assessment routes.
• Advise leadership on regulatory risks, timelines, and commercialization requirements.
• Interpret and apply EU IVDR (Regulation (EU) 2017/746) requirements.

• Lead preparation and review of CE-IVDR technical documentation.
• Develop regulatory deliverables including:
  • Intended Use Statements
  • Performance Evaluation Plans (PEP)
  • Performance Evaluation Reports (PER)
  • Risk Management Files
  • Clinical Performance Documentation
  • Analytical Performance Documentation
  • Labeling and IFU content
  • Post-Market Surveillance Plans
• Ensure traceability across design controls and technical documentation.

• Adviseonanalytical and clinical performance studiesrequiredfor CE-IVDR submission.
• Review study protocols andevidencepackages supporting intended use claims.
• Ensure alignment of clinical validation data with CE-IVDR expectations.

• Support Notified Bodyselectionand engagement strategy.
• Participate in regulatory meetings and audits.
• Prepare and coordinate deficiency responses and remediation plans.
• Serve asregulatorysubject matter expert during submission activities.

• Partner with QA and product development teams to establish IVDR-compliant design controls.
• Ensure alignment between product development, manufacturing, and regulatory requirements.
• Review SOPs, DHF, risk management, and validation documentation.
• Provide guidance on post-market surveillance and vigilance activities.

• Review regulatory aspects of kit development and manufacturing transfer activities.
• Supportqualificationof CE-IVDR-capable CDMO partners.
• Ensure regulatory requirements are incorporated into manufacturing and quality agreements.
• Review stability, QC, and release testing strategies supporting CE-IVDR submissions.

• Bachelor's degree or higher in Regulatory Affairs, Biology, Molecular Biology, Life Sciences, or related field.
• Minimum 8 years of IVD regulatory experience.
• Direct experience leading CE-IVDR submissions.
• Strong understanding of EU IVDR (2017/746).
• Experience preparing CE-IVDR technical files and performance evaluation documentation.
• Experience working with Notified Bodies.
• Experience supporting oncology molecular diagnostics, NGS assays, liquid biopsy, or precision oncology products.
• Strong project management and communication skills.

• RAC certification and/or advanced regulatory credentials.
• Experience with oncology MRD, ctDNA, liquid biopsy, or companion diagnostics.
• Experience with distributed kit products and CDMO manufacturing models.
• Knowledge of ISO 13485 and European quality system requirements.
• Prior experience supporting US FDA and global regulatory submissions.

• Approximately
  10–20 hours per week initially.
• Increased involvement during technical file preparation and submission phases.
• Flexible remote engagement.
• Occasional travel for partner,Notified Body, or project meetings may be required.

The ideal candidate has successfully led CE-IVDR submissions for oncology molecular diagnostics, liquid biopsy, NGS, or companion diagnostic products and has firsthand experience interacting with Notified Bodies. Experience bringing a novel molecular assay from development through CE-IVDR commercialization would be highly desirable.